Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 29

Results For "operations"

739 News Found

Takeda emphasizes DEI to bring equal opportunities for all at the G20 Summit
News | September 08, 2023

Takeda emphasizes DEI to bring equal opportunities for all at the G20 Summit

The biopharmaceutical leader shared its expert perspective at the Equality Lounge at the G20 Summit


Gautam Solar donates medical equipment to AIIMS Delhi burns ward
News | September 08, 2023

Gautam Solar donates medical equipment to AIIMS Delhi burns ward

The generous donation includes multiple medical equipments


Biocon Biologics completes integration of Viatris Biosimilars’ business in North America
News | September 07, 2023

Biocon Biologics completes integration of Viatris Biosimilars’ business in North America

Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris


Loop's health assurance model drives 200% YoY premium surge across 1000 companies
Healthcare | September 02, 2023

Loop's health assurance model drives 200% YoY premium surge across 1000 companies

Health Assurance is a unique healthcare model that combines health insurance with preventive healthcare with a focus on keeping people healthy while providing sick care for them when needed


India's digital startup ecosystem a catalyst for global healthcare transformation: Piyush Goyal
Digitisation | September 02, 2023

India's digital startup ecosystem a catalyst for global healthcare transformation: Piyush Goyal

Robots make it to the healthcare conference panel, reflecting the future potential of technology


Jupiter Life Line Hospitals’ IPO to open on Sept. 6
News | September 02, 2023

Jupiter Life Line Hospitals’ IPO to open on Sept. 6

Sets price band at ?695 to ?735 per Equity Share


Sanofi announces changes to its Executive Committee
People | September 01, 2023

Sanofi announces changes to its Executive Committee

Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.


Gland Pharma receives 2 observations under 483 for Pashamylaram facility
News | August 28, 2023

Gland Pharma receives 2 observations under 483 for Pashamylaram facility

The company is committed to address the observations and will submit its response to US FDA within the stipulated time


Shiva Pharmachem files DRHP for its Rs. 900 crore IPO
News | August 22, 2023

Shiva Pharmachem files DRHP for its Rs. 900 crore IPO

The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment


Collaborative efforts and equitable access to diagnostic prevention needed to end TB: Dr. Mandaviya
Policy | August 19, 2023

Collaborative efforts and equitable access to diagnostic prevention needed to end TB: Dr. Mandaviya

Combating the prevalent stigma against TB in the society, India has been committed to providing, enabling and patient-centric support to all, individuals suffering from TB